Search research articles
Contact Us
Filters
Showing results (41-50 of 58) with videos related to
Page
of 6
Sort By:
Diabetes & Metabolism
|
September 16, 2006
Efficacy of short term continuous subcutaneous insulin lispro versus continuous intravenous regular insulin in poorly controlled, hospitalized, type 2 diabetic patients
S Boullu-Sanchis, F Ortega, G Chabrier, et al.
Neurology
|
November 1, 1984
Increase of valproate-induced hyperammonemia in normal subjects by carbohydrate intake
J M Warter, C Marescaux, G Chabrier, et al.
Revue Neurologique
|
January 1, 1983
[Role of hyperammonemia in stuporous states induced by sodium valproate]
J M Warter, C Marescaux, L Rumbach, et al.
La Revue De Medecine Interne
|
July 1, 1991
[Hyperthyroidism and immune hemolytic anemia following amiodarone therapy]
M P Arpin, M Alt, J C Kheiralla, et al.
Neurology
|
September 1, 1983
The renal origin of sodium valproate-induced hyperammonemia in fasting humans
J M Warter, C Brandt, C Marescaux, et al.
Epilepsia
|
October 1, 1983
Sodium valproate associated with phenobarbital: effects on ammonia metabolism in humans
J M Warter, C Marescaux, C Brandt, et al.
Annales D'Endocrinologie
|
February 23, 2008
Association of malignant insulinoma and type 2 diabetes mellitus: a case report
J Schmitt, S Boullu-Sanchis, F Moreau, et al.
Presse Medicale (Paris, France : 1983)
|
November 24, 1984
[Thyroid function in euthyroid patients treated with amiodarone]
J L Schlienger, M Villard, F Vignon, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
August 1, 1986
[Ultra-sensitive TSH levels: an aid in the screening for amiodarone-induced thyroid dysfunction]
J L Schlienger, M C Dickelé, G Roul, et al.
Oncogene
|
June 15, 1995
RET mutations in exons 13 and 14 of FMTC patients
A Bolino, I Schuffenecker, Y Luo, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 58) with videos related to
Sort By:
Page
of 6
Diabetes & Metabolism
|
September 16, 2006
Efficacy of short term continuous subcutaneous insulin lispro versus continuous intravenous regular insulin in poorly controlled, hospitalized, type 2 diabetic patients
S Boullu-Sanchis, F Ortega, G Chabrier, et al.
Neurology
|
November 1, 1984
Increase of valproate-induced hyperammonemia in normal subjects by carbohydrate intake
J M Warter, C Marescaux, G Chabrier, et al.
Revue Neurologique
|
January 1, 1983
[Role of hyperammonemia in stuporous states induced by sodium valproate]
J M Warter, C Marescaux, L Rumbach, et al.
La Revue De Medecine Interne
|
July 1, 1991
[Hyperthyroidism and immune hemolytic anemia following amiodarone therapy]
M P Arpin, M Alt, J C Kheiralla, et al.
Neurology
|
September 1, 1983
The renal origin of sodium valproate-induced hyperammonemia in fasting humans
J M Warter, C Brandt, C Marescaux, et al.
Epilepsia
|
October 1, 1983
Sodium valproate associated with phenobarbital: effects on ammonia metabolism in humans
J M Warter, C Marescaux, C Brandt, et al.
Annales D'Endocrinologie
|
February 23, 2008
Association of malignant insulinoma and type 2 diabetes mellitus: a case report
J Schmitt, S Boullu-Sanchis, F Moreau, et al.
Presse Medicale (Paris, France : 1983)
|
November 24, 1984
[Thyroid function in euthyroid patients treated with amiodarone]
J L Schlienger, M Villard, F Vignon, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
August 1, 1986
[Ultra-sensitive TSH levels: an aid in the screening for amiodarone-induced thyroid dysfunction]
J L Schlienger, M C Dickelé, G Roul, et al.
Oncogene
|
June 15, 1995
RET mutations in exons 13 and 14 of FMTC patients
A Bolino, I Schuffenecker, Y Luo, et al.
Page
of 6